Gregory J Riely

Title: Innovations by Gregory J Riely

Introduction

Gregory J Riely is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 3 patents, Riely has focused on developing innovative dosing regimens that enhance the efficacy of existing treatments.

Latest Patents

One of Riely's latest patents is centered around a novel dosing regimen for erlotinib, a medication used in the treatment of non-small cell lung cancer (NSCLC). This patent describes a pulse dosing regimen that demonstrates impressive control of central nervous system disease, surpassing the effectiveness of standard dosing methods. The regimen is particularly beneficial for patients with NSCLC harboring epidermal growth factor receptor (EGFR) mutations, with or without pre-existing brain metastases.

Career Highlights

Riely is associated with Osi Pharmaceuticals, Inc., where he continues to innovate in the field of cancer therapeutics. His work has been instrumental in advancing treatment options for patients suffering from complex conditions.

Collaborations

Throughout his career, Riely has collaborated with esteemed colleagues such as Stanley C Gill and Kenneth K Iwata. These partnerships have contributed to the development of groundbreaking treatments and methodologies in oncology.

Conclusion

Gregory J Riely stands out as a significant figure in the realm of pharmaceutical innovation. His contributions, particularly in the area of cancer treatment, reflect a commitment to improving patient outcomes through advanced therapeutic strategies.